ArticleBMC psychiatry2026
Assessment of depression and pain in the general population: a scoping review.
Article in BMC psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDepression and pain, which often overlap, are highly prevalent in the general population. However, the available evidence synthesis on their comorbidity is limited to specific patients. We aimed to give an overview on the assessment of co-occurring depression and pain in the general population focusing on measurements for both disorders.
methodsThis scoping review was registered ( https://doi.org/10.17605/OSF.IO/DCE3Q ) and received no funding. MEDLINE (via PubMed), PsycINFO (via EBSCOhost) and EMBASE (via Elsevier) were searched from inception to 10th of December 2024. Cross-sectional and cohort studies with ≥ 100 participants ≥ 14 years, presenting prevalences and/or effect estimates for both depression and pain were included. Data analysis was performed following the principles of Arksey and O´Malley.
resultsWe screened 16.916 records and included 60 studies reported in 61 articles, published between 2001 and 2024, of which 42 were cross-sectional and 18 were cohort-studies. Depression was assessed with 19 different measurements, including 17 instruments (most often CES-D, GDS and PHQ), and 2 question based measures. Pain was assessed with 20 different measurements, including 17 instruments (most often VAS, BPI and FPS-R), and 3 question-based measures. The reported comorbid prevalence varied: pain by depression 6.8-87% (median: 50.2%; n = 12) and depression by pain 11-84.5% (median: 46.5%; n = 14).
conclusionDepression and pain show high mutual comorbidity in the general population (about 50%), but measurements in the literature were heterogenous in terms of versions, cut-offs, definitions or assessed characteristics. In patients with either depression or pain, we propose a standardized initial assessment also considering the multidimensionality of pain. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.